Yibin Zhang

发表

Development of a novel PROTAC using the nucleic acid aptamer as a targeting ligand for tumor selective degradation of nucleolin

Xing Sun, Mao Ye, Jing Liu, 2022 .

Constructing a warhead of PROTAC with aptamer for tumor-selective degradation of nucleolin

Mao Ye, Jing Liu, Ling Li, 2021, Molecular Therapy - Nucleic Acids.

CD71-Specific Aptamer Conjugated with Monomethyl Auristatin E for the Treatment of Uveal Melanoma.

Y. Liu, Mao Ye, Lin Zhang, 2021, ACS applied materials & interfaces.

Molecular Recognition and In-Vitro-Targeted Inhibition of Renal Cell Carcinoma Using a DNA Aptamer

W. Xiong, W. Tan, Mao Ye, 2018, Molecular therapy. Nucleic acids.

Deubiquitylase USP7 regulates human terminal erythroid differentiation by stabilizing GATA1

C. Hillyer, Mao Ye, N. Mohandas, 2019, Haematologica.

Cigarette smoke extract-mediated FABP4 upregulation suppresses viability and induces apoptosis, inflammation and oxidative stress of bronchial epithelial cells by activating p38 MAPK/MK2 signaling pathway

Yibin Zhang, Qiliong Zhu, Wei Zhang, 2022, Journal of inflammation.

Development of a novel PROTAC using the nucleic acid aptamer as a targeting ligand for tumor selective degradation of nucleolin

Xing Sun, Mao Ye, Liu, 2022, Molecular Therapy. Nucleic Acids.

Elucidation of CKAP4-remodeled cell mechanics in driving metastasis of bladder cancer through aptamer-based target discovery

Zilong Zhao, Xing Sun, Mao Ye, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Deubiquitylation and stabilization of p21 by USP11 is critical for cell-cycle progression and DNA damage responses

Mao Ye, Jing Liu, Peifu Feng, 2017, Proceedings of the National Academy of Sciences.

Screening and characterization of an Annexin A2 binding aptamer that inhibits the proliferation of myeloma cells.

Yayue Zeng, Mao Ye, Shuming Sun, 2018, Biochimie.

MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4

Mao Ye, Weihua Zhou, Jing Liu, 2016, Scientific Reports.

Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC

Yayue Zeng, Mao Ye, X. An, 2015, Oncotarget.

Development of a DNA Aptamer against Multidrug-Resistant Hepatocellular Carcinoma for In Vivo Imaging.

Xing Sun, Mao Ye, Jing Liu, 2021, ACS applied materials & interfaces.

Aptamer-Mediated Enrichment of Rare Circulating Fetal Nucleated Red Blood Cells for Noninvasive Prenatal Diagnosis.

Xing Sun, Mao Ye, Ying Peng, 2023, Analytical chemistry.

Nucleic acid aptamer controls mycoplasma infection for inhibiting the malignancy of esophageal squamous cell carcinoma.

Xing Sun, Mao Ye, Ling Li, 2022, Molecular Therapy.

Development of a novel PROTAC using the nucleic acid aptamer as a targeting ligand for tumor selective degradation of nucleolin

Xing Sun, Mao Ye, Liu, 2022, bioRxiv.

Albendazole inhibits NF-κB signaling pathway to overcome tumor stemness and bortezomib resistance in multiple myeloma.

Mao Ye, Xiaojuan Xiao, Jing Liu, 2021, Cancer letters.

Anti-BCMA surface engineered biomimetic photothermal nanomissile enhances multiple myeloma cell apoptosis and overcomes the disturbance of NF-κB signaling in vivo.

Mao Ye, Xiaojuan Xiao, Xifeng Liu, 2023, Biomaterials.

A Novel Aptamer LL4A Specifically Targets Vemurafenib-Resistant Melanoma through Binding to the CD63 Protein

Mao Ye, Shuming Sun, Weihua Zhou, 2019, Molecular therapy. Nucleic acids.

Generation of DNA Aptamers with Functional Activity in Mammalian Cells by Mimicking Retroviruses.

Mao Ye, Jing Liu, Neng Ling, 2023, Analytical chemistry.

Development of Uveal Melanoma-Specific Aptamer for Potential Biomarker Discovery and Targeted Drug Delivery.

Mao Ye, Yikui Zhang, Yibin Zhang, 2023, Analytical chemistry.

[Research advances in the role of aptamers in the diagnosis and targeted therapy of pediatric cancer].

Yibin Zhang, Yanpeng Wang, Jing Liu, 2018, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.